American Association for Cancer Research (AACR) Annual Meeting 2025

Meet Matthew Hoover, our Director, Business Development

Matthew Hoover is an enthusiastic member of team ImaginAb, with a passion for nuclear medicine and PET/CT imaging.

Matt is responsible for driving business development and marketing initiatives with a focus on further expanding the utilization of CD8 ImmunoPET among biotech and pharmaceutical companies.

Prior to joining ImaginAb, Matthew has worked in a number of business development roles and has spent valuable time building an international oncology imaging core lab service offering for an imaging contract research organization. This experience allowed him to contribute to the global landscape of oncology imaging services, highlighting his versatility and dedication to advancing healthcare solutions.

Outside of the office, Matthew enjoys spending time with his wife and three young children. He can oftentimes be found at either a lacrosse field, gymnastics practice or meet, or soccer field and occasionally finds the time to go kayaking, hiking, and play in his garden.

Meet Calmen Tihansky, our Manager, Business Development

Calmen is a friendly and personable key member of ImaginAb, helping immunotherapy drug developers to access CD8 ImmunoPET in their clinical trials. He also manages our CRM platform and collaborates with Marketing on external communications.

Calmen started at ImaginAb as an ‘intern’ and progressed to a full-time marketing role, followed by a hybrid Sales and Marketing position. Calmen attributes his development at ImaginAb to working with several teams of Business Development representatives, and the unique opportunity to interact closely with Team ImaginAb’s senior leadership.

Outside of ImaginAb, Calmen enjoys mountain sports, city exploration, being active, and traveling to visit his friends and family.